Published on: Jul 15, 2016 at Cure Today

Immunotherapy Continues to Show Promise in Treating Gastric Cancers

By : Cure Today

In the phase 1b JAVELIN trial, pretreated patients with gastric/gastroesophageal junction cancers (GC/GEJ) responded well to avelumab, a PD-L1 antibody.

 

Read More
SHARE